Juvena Therapeutics
Redwood City, US · Founded 2017 · Delaware corporation · 10 known investors
Juvena Therapeutics develops biologics derived from human secreted proteins to treat aging-related diseases, using AI-enabled drug discovery to identify tissue-restorative therapeutics for muscle and metabolic disorders.
Founders & leadership
JO
Jeremy O'Connell, PhDChief Scientific Officer and Co-Founder
HY
Hanadie Yousef, PhDExecutive Advisor and Co-Founder
SJ
Steven JamesinDirector
SJ
Stephen JuelsgaardinDirector
HY
Hanadie YousefExecutive Officer, Director
LL
Laura Lande-DinerinDirector
CK
Christopher KirkDirector
AA
Ayman AlAbdallahDirector
JO
Jeremy O'ConnellDirector
BH
Ben HemaniinDirector
Investors · 10
Bascom VenturesBoston
Bison VenturesSeattle
CompoundNew York · $400K – $1.5M
Harmonix FundLa Quinta
Horizons VenturesHong Kong · $1M – $110M
Manta Ray VenturesLondon
Open Field CapitalNew York
Plum Alley InvestmentsNew York · $500K – $1.5M
Transform Capital ManagementSan Francisco
BoxOne VenturesreportedMontréal · $500K
Reported raises · per SEC filings
Form D private placements▶$30.5MraisedJul 2025 · 12 investors · Other TechnologyRule 506(b)
▶$30.5MraisedJul 2025 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Steven JamesDirector
- Ben HemaniDirector
- Stephen JuelsgaardDirector
- Hanadie YousefExecutive Officer, Director
- Laura Lande-DinerDirector
- Christopher KirkDirector
- Ayman AlAbdallahDirector
- Jeremy O'ConnellDirector
- Offering amount
- $41M
- Amount sold
- $30.5M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.3MraisedFeb 2018 · 23 investors · Other TechnologyRule 506(b)
▶$4.3MraisedFeb 2018 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Hanadie YousefExecutive Officer, Director
- Offering amount
- $4.3M
- Amount sold
- $4.3M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Regenerative Medicine Startup Funding (2026) – New Market Pitchnewmarketpitch.com · 2026
- Juvena lands $33.5m to advance more regenerative biologics to the cliniclongevity.technology · 2026
- Juvena Therapeutics Raises $33.5M in Series B Fundingfinsmes.com · 2026
- Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipelinebusinesswire.com · 2026
- Juvena Therapeutics has filed a notice of an exempt offering of securities to raise $41 Million in New Funding. - intelligence360intelligence360.news · 2025